These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 26201264)
1. High-Dose Chemotherapy and Autologous Stem Cell Transplant in Older Patients with Lymphoma. Lahoud OB; Sauter CS; Hamlin PA; Dahi PB Curr Oncol Rep; 2015 Sep; 17(9):42. PubMed ID: 26201264 [TBL] [Abstract][Full Text] [Related]
2. A Review of Autologous Stem Cell Transplantation in Lymphoma. Zahid U; Akbar F; Amaraneni A; Husnain M; Chan O; Riaz IB; McBride A; Iftikhar A; Anwer F Curr Hematol Malig Rep; 2017 Jun; 12(3):217-226. PubMed ID: 28478586 [TBL] [Abstract][Full Text] [Related]
3. High-dose thiotepa-based chemotherapy with autologous stem cell support in elderly patients with primary central nervous system lymphoma: a European retrospective study. Schorb E; Fox CP; Fritsch K; Isbell L; Neubauer A; Tzalavras A; Witherall R; Choquet S; Kuittinen O; De-Silva D; Cwynarski K; Houillier C; Hoang-Xuan K; Touitou V; Cassoux N; Marolleau JP; Tamburini J; Houot R; Delwail V; Illerhaus G; Soussain C; Kasenda B Bone Marrow Transplant; 2017 Aug; 52(8):1113-1119. PubMed ID: 28436974 [TBL] [Abstract][Full Text] [Related]
4. [Autologous hematopoietic stem cell transplantation for aggressive B-cell non-Hodgkin's lymphoma]. Hirose A; Yamane T; Nakajima Y; Manabe M; Kanashima H; Hagihara K; Sakamoto E; Nakamae M; Terada Y; Kosaka S; Aoyama Y; Sakamoto C; Kumura T; Koh KR; Hirai M; Ohta K; Nakao Y; Mugitani A; Teshima H; Hino M Gan To Kagaku Ryoho; 2005 Dec; 32(13):2059-64. PubMed ID: 16352929 [TBL] [Abstract][Full Text] [Related]
5. Clinical features of life-threatening complications following autologous stem cell transplantation in patients with lymphoma. Kerhuel L; Amorim S; Azoulay E; Thiéblemont C; Canet E Leuk Lymphoma; 2015; 56(11):3090-5. PubMed ID: 25813206 [TBL] [Abstract][Full Text] [Related]
6. Post-treatment work patterns amongst survivors of lymphoma treated with high-dose chemotherapy with autologous stem-cell transplantation. Hernæs KH; Smeland KB; Fagerli UM; Kiserud CE BMC Cancer; 2021 Feb; 21(1):143. PubMed ID: 33557789 [TBL] [Abstract][Full Text] [Related]
7. Upfront autologous stem cell transplantation for untreated high-risk diffuse large B-cell lymphoma in patients up to 60 years of age. Takasaki H; Hashimoto C; Fujita A; Matsumoto K; Taguchi J; Kuwabara H; Yamazaki E; Koharazawa H; Fujita H; Fujisawa S; Ishii Y; Yamamoto W; Motomura S; Tomita N; Ishigatsubo Y; Sakai R Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):404-9. PubMed ID: 23763919 [TBL] [Abstract][Full Text] [Related]
8. High-dose chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: complete response at transplant predicts survival. Kim MK; Kim S; Lee SS; Sym SJ; Lee DH; Jang S; Park CJ; Chi HS; Huh J; Suh C Ann Hematol; 2007 Jun; 86(6):435-42. PubMed ID: 17256144 [TBL] [Abstract][Full Text] [Related]
9. High-dose chemotherapy followed by autologous stem cell transplantation as first-line therapy in aggressive non-Hodgkin's lymphoma: a meta-analysis. Strehl J; Mey U; Glasmacher A; Djulbegovic B; Mayr C; Gorschlüter M; Ziske C; Schmidt-Wolf IG Haematologica; 2003 Nov; 88(11):1304-15. PubMed ID: 14607760 [TBL] [Abstract][Full Text] [Related]
10. High-dose therapy and autologous stem cell transplantation for extra-nodal NK/T lymphoma in patients from the Western hemisphere: a study from the European Society for Blood and Marrow Transplantation. Fox CP; Boumendil A; Schmitz N; Finel H; Luan JJ; Sucak G; Blaise D; Finke J; Pflüger KH; Veelken H; Gorin NC; Poiré X; Ganser A; Dreger P; Sureda A Leuk Lymphoma; 2015; 56(12):3295-300. PubMed ID: 25899403 [TBL] [Abstract][Full Text] [Related]
11. High-dose chemotherapy for Ewing sarcoma and Rhabdomyosarcoma: A systematic review by the Australia and New Zealand sarcoma association clinical practice guidelines working party. Ramamurthy A; Connolly EA; Mar J; Lewin J; Bhadri VA; Phillips MB; Winstanley M; Orme LM; Grimison P; Connor J; Lazarakis S; Hong AM; Omer N; Cayrol J Cancer Treat Rev; 2024 Mar; 124():102694. PubMed ID: 38325070 [TBL] [Abstract][Full Text] [Related]
12. High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma. Illerhaus G; Marks R; Ihorst G; Guttenberger R; Ostertag C; Derigs G; Frickhofen N; Feuerhake F; Volk B; Finke J J Clin Oncol; 2006 Aug; 24(24):3865-70. PubMed ID: 16864853 [TBL] [Abstract][Full Text] [Related]
14. Autologous stem cell transplantation with busulfan, cyclophosphamide, and etoposide as an intensifying frontline treatment in patients with peripheral T cell lymphomas: a multicenter retrospective trial. Ahn JS; Yang DH; Jung SH; Chae YS; Sohn SK; Yhim HY; Kwak JY; Lee SR; Kim YK; Kim HJ; Lee JJ Ann Hematol; 2013 Jun; 92(6):789-97. PubMed ID: 23358616 [TBL] [Abstract][Full Text] [Related]
15. R-CHOP or R-HyperCVAD with or without autologous stem cell transplantation for older patients with mantle cell lymphoma. Frosch Z; Luskin MR; Landsburg DJ; Schuster SJ; Svoboda J; Loren AW; Porter DL; Stadtmauer EA; Nasta SD Clin Lymphoma Myeloma Leuk; 2015 Feb; 15(2):92-7. PubMed ID: 25174772 [TBL] [Abstract][Full Text] [Related]
16. Role of hematopoietic stem cell transplantation for advanced-stage diffuse large cell B-cell lymphoma-B. Nademanee A; Forman SJ Semin Hematol; 2006 Oct; 43(4):240-50. PubMed ID: 17027658 [TBL] [Abstract][Full Text] [Related]
17. High-dose therapy and autologous stem cell transplantation in patients with diffuse large B-cell lymphoma in first complete or partial remission. Papajik T; Raida L; Faber E; Vondrakova J; Prochazka V; Kubova Z; Skoumalova I; Jarosova M; M LK; Paucek B; Myslivecek M; Neoral C; Oral I; Jarkovsky J; Dusek L; Indrak K Neoplasma; 2008; 55(3):215-21. PubMed ID: 18348654 [TBL] [Abstract][Full Text] [Related]
18. Hematopoietic cell transplantation for lymphomas. Ayala E; Tomblyn M Cancer Control; 2011 Oct; 18(4):246-57. PubMed ID: 21976243 [TBL] [Abstract][Full Text] [Related]
19. [High dose therapy with autologous stem cell transplantation in patients with Hodgkin's lymphoma: long-term follow-up in patients treated in one center]. Trnĕný M; Vacková B; Pytlík R; Cieslar P; Válková V; Gasová Z; Kobylka P; Trnková M; Krejcová H; Klener P Cas Lek Cesk; 2006; 145(1):19-24. PubMed ID: 16468237 [TBL] [Abstract][Full Text] [Related]
20. Pre-transplant positron emission tomography (PET) using fluorine-18-fluoro-deoxyglucose (FDG) predicts outcome in patients treated with high-dose chemotherapy and autologous stem cell transplantation for non-Hodgkin's lymphoma. Cremerius U; Fabry U; Wildberger JE; Zimny M; Reinartz P; Nowak B; Schaefer W; Buell U; Osieka R Bone Marrow Transplant; 2002 Jul; 30(2):103-11. PubMed ID: 12132049 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]